Next-generation tissue-engineered neural interfaces that create bidirectional communication between the peripheral nervous system and digital technology.
Proudly partnered with
Supported by patented IP developed at the University of Florida
Axolink is commercializing patented peripheral nerve interface technology from the University of Florida. Our platform integrates dense 3-D microelectrode arrays into decellularized nerve allografts to create a fundamentally new class of neural interface.
Unlike traditional approaches that use rigid electrodes, our technology promotes natural nerve regeneration around the electrodes — enabling intimate, long-term integration with minimal foreign body response.
By focusing on the peripheral nervous system, we deliver a safer, more accessible pathway to bidirectional neural connectivity across prosthetics, pain management, bioelectronic medicine, and beyond.
Preclinical nerve repair, reconstruction, and device integration.
Clinical-grade microsurgical execution for preclinical nerve repair, reconstruction, and device integration.
Sciatic models. Nerve transection. Allografts. Conduits. Tension-free, reproducible reconstruction.
TMR. RPNI. Hybrid nerve reconstruction. Executed with true surgical fidelity.
Intra-nerve and intra-graft electrode placement. Seamless integration with regenerating tissue.
Weeks to months. Stable lead management. Reliable outcomes.
Device-specific implantation strategies. Iterative refinement. Translation-focused design.
Reconstructive plastic surgery–based technique. Refined through annual hands-on cadaver training with AASH, ASPN, and ASRM in nerve repair, fixation, and flap reconstruction.
Stingray-shaped polyimide microelectrode arrays integrated into decellularized nerve allografts, leveraging native ECM architecture to guide axon regeneration directly around electrodes.
Stingray-shaped polyimide-metal microelectrode arrays enabling two parallel thread sets from a single bond-pad array — maximizing channel density while simplifying packaging and surgical complexity.
Clinically proven nerve allografts preserve native ECM architecture and structural cues, providing superior axonal guidance compared to synthetic hydrogel scaffolds.
Nerves regenerate naturally through the allograft and around the 3-D microelectrode array, achieving intimate electrode-tissue contact with improved geometric stability.
Read the paper here.
Thought-driven prosthetic limb control with naturalistic sensory feedback, restoring high-degree-of-freedom movement and the sense of touch for amputees.
Targeted peripheral nerve stimulation that modulates pain signaling directly, offering precise, drug-free alternatives for chronic pain and phantom limb pain.
Precision stimulation of peripheral nerve pathways to modulate organ function, treating inflammatory, metabolic, and autoimmune conditions at their neural origin.
Seamless neural interfaces for next-generation devices, from surgical robotics to industrial exoskeletons, extending the boundaries of human performance.
Deep expertise in neural engineering, biomedical device development, and MEMS microfabrication from the University of Florida.



We believe tissue-engineered peripheral nerve interfaces will reshape how humans interact with technology.
Partner With UsResearchers, clinicians, investors, and partners are welcome. Fill out the form and we'll be in touch.